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1) Kobayashi K., Hamazaki K., Fujioka S., Terao K., Yamamoto J., and Kobayashi S.: The 
effect of n-3 PUFA/y-cyclodextrin complex on serum lipids in healthy vol磁殺をeers? a 
randomized, placebo醐controlled,double-blind trial. Asia Pac J. Clin. Nutr.円 16:429-434, 
2007. 
OBJECTIVES: This study was carried out to examine whether serum triglyceride concentrations were 
decreased by administration ofn-3 polyunsaturated fatty acid (PUFA)/gamma“cyclodextrin (gamma-CD) 
complex幽containingcapsules as reported previously with n-3PUFA without gamma-CD. STじDY
DESIGN: A placebo事controlled double-blind study with healthy subjects (n=35) and 
hypertriglyceridemic subjects (n=7) of 35-66 years of age was performed. The subjects were randomized 
to a group (n-3 group) supplemented with n-3PUFA/gamma-CD畑containingcapsules ( 660 mg EPA÷280 
mg DHA/day) or a control group supplemented with capsules containing essentially no n-3 PUFA for 8 
weeks with stratification by sex, age, and serum triglyceride levels in a double blind manner. Fasting 
blood samples were obtained at the start of administration and・ 4 and 8 weeks afterward. RESULTS: EPA 
concentrations in the total ph pholipid fraction of red blood cells increased significantly in al subjects in 
then剛． 
decreased (-17%) in the n-3 group compared with the control group at week 8. The following serum lipids 
did not significantly change over time: total”cholesterolラ ・low-densitylipoprotein-cholesterol and 
high糊densitylipoprotein聞cholesterol.Only two subjects in the n-3 group guessed at the end of the study 
that their capsules were active. CONCLUSION: n-3 PUFA/gamma”CD complex lowered triglyceride 
levels in normal and slightly hypertriglyceridemic subjects. There was a possibility that gamma-CD 
might at least partly cover the smell and aftertaste of fish oil. 
2) Hamazaki K., Sawazaki S吋註omuraE仁HuanM., Shibahara N., Kawakita I均五obayashiS叫
Hamazaki T.: No effect of a traditional Chinese medicine, Hochu-ekki-to, on anitibody titer 
after influenza vaccination in man: A randomized, placebo-controlled, double欄blindtrial. 
Phytomedicine, 14: 11-14, 2007. 
BACKGROUND: It was shown that a traditional Chinese medicine, Hochu-ekki-to (HET), had a司juvant
effects in influenza vaccination in an animal experiment. This, however, could not be assessed in a clinical 
study. METHODS: Thirty-two healthy subjects were randomly assigned to two groups (control and HET 
groups) in a double閑blindmanne工HETsubjects (n=l 7) took 7.5 g of HET/day for two weeks; control 
subjects took the same amount of indistinguishable placebo. Then subjects were vaccinated against 
influenza (HlNl, H3N2 and B/Shandong). Hemagglutinin titers and natural killer (NK) activity were 
measured at weeks Oラ 1,2ラ4ラand12. RESULTS: Antiinfluenza titers against the three viruses were 
increased continuously for the first two weeks and leveled of. However, there were no significant 
differences in any titers between the two groups. NK activity peaked at week 2 without any inter-group 
differences. CONCLUSION: We could not find any a司juvanteffects of HET in this experimental 
condition. 
3) Terashima Y., Hamazaki K., Itomura M円 HuanM., Shibahara N., Kobayashi S叫 Hamazaki
T.: Effect ofをraditionalChinese medicineラmaobushisaishin紛争 onthe antibody titer after 
influenza vaccination : A randomized, placebo-controlled, double-blind trial. J. trad. Med., 
24:59・66,2007. 
Background: It was shown that a traditional Chinese medicine, maobushisaishinto (MBST), had 
a司juvanteffects on influenza vaccination in an animal experiment and an open trial in elderly subjects. 
Purpose: To examine the adjuvant effects ofMBST in a closer clinical experiment. Methods: Forty-seven 
healthy subjects between 20 and 71 y of age were randomly assigned to two groups (control and MBST 
groups) in a double“blindmanne工Thesubjects in the MBST group (n=23) took l .68g spray-dried powder 
-84-
ofMBST/day for two weeks; the rest (control subjects, n=24) took the same amount of indistinguishable 
placebo. Then ubjects were vaccinated against influenza viruses (A/HlNl, A/H3N2 and B). Serum 
hemagglutination inhibition titers were measured at weeks 0, 1, 2, 4, and 12. Results: The titers against the 
three viruses were increased continuously for the first two weeks and leveled of. However, MBST was 
not superior to placebo in any titers. Conclusion: We could not find any adjuvant effects of MBST in this 
experimental condition. 
4) Kumasaka R叫 NakamuraN吋 YamabeH., Osawa H., Shirato K., Shimada M刊 MurakamiR., 
Fujita T., Okumura K., Hamazaki K. and Hamazaki T.: Fatty acid composi“on of plasma 
and kidney in rats with anti-thyl.1 nephritis. in vivo, 21: 77-80,2007. 
BACKGROUND: n-3 Polyunsaturated fatty acids (PUFA) are reported to ameliorate atherosclerotic and 
inflammatory diseases because they compete with arachidonic acid and reduce its inflammatory 
metabolites. In the present study, the fatty acid composition of plasma and kidney in rats with anti-Thy 1.1 
nephritis was investigated. MATERIALS AND METHODS: A group of male Wister rats weighing about 
200 g was i吋ectedwith anti-Thy 1.1 antibody ( 1.25 mL/kg) through their tail veins (nephritis group). Rats 
in the control group were injected with saline. Five days after the injection, urinary protein levels were 
determined. All rats were then sacrificed and fatty acid composition of plasma and kidney were analyzed. 
RESULTS: Eicosapentaenoic acids (EPA) levels in the kidney phospholipid (PL）企actionin the nephritis 
group were significantly lower than those in the control group (0.67十／ー 0.06mol% vs. 0.96 ＋／ー 0.06
mol%, p < 0.05). EPA levels in the plasma PL fraction in the nephritis group were also significantly lower 
than those in the control group (0.38 ＋／ー 0.05mol% vs. 0.59 +/-0.03 mol%, p < 0.05). Urinary protein 
levels 5 days after the injection were inversely correlated with EPA levels in the kidney PL fraction (r2 = 
0.65, p = 0.01 ).These results suggested that decreased EPA levels in the kidney PL fraction might play an 
important role in anti-Thy 1.1 nephritis. 
5) Yamada Y., Yamamoto R. and Watanabe S.: Scutellariae Radix enhances but Scutellariae 
Radix-containing Kampo formulas, Orengedokuto and San'oshashinto, prevent intestinal 
bleeding associated with indomethacin-induced enteropathy in mice. J. Trad. Med., 24: 
128圃136,2007. 
A single subcutaneous injection of indomethacin (INDO) in mice induced enteropathy characterized as 
ulceration in small intestine, which was associated with the elevation of fecal hemoglobin (Hb) content 
and the decrease in Hb and total protein concentration in blood. Oral administration of Scutellariae Radix 
(SR) (500 mg/kg) enhanced fecal Hb excretion but did not affect the decrease in blood Hb and total 
protein concentration in INDO-treated mice. In contrast, administration of two SR-containing kampo 
formulas, Orengedokuto (OGT) and San'oshashinto (SST) at 1100 mg/kg, which contained nearly the 
same amounts of baicalin as SR extracts at 500 mg/kg, markedly suppressed INDO-induced intestinal 
bleeding and blood los. Plasma INDO concentration was not changed by the administration of SR, OGT 
or SST. The present study suggests that OGT and SST are useful for limiting complications such as 
intestinal bleeding and blood loss associated with INDO・inducedenteropathy. However, possible harmful 
effects of other SR-containing kampo formulas on INDO-induced enteropathy remain to be investigated. 
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